- Published at
- by gurufocus.com
mixed
mixed
News for Ikena Oncology, Inc. (IKNA)
- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveHUTCHMED Reports 2024 Full Year Results and Provides Business Updates
65% oncology products revenue growth drove profitable operation and supported new ATTC platform HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveDeep Track Capital, LP Acquires Significant Stake in Ikena Oncology Inc
On February 7, 2025, Deep Track Capital, LP (Trades, Portfolio) executed a strategic acquisition of 2,515,513 shares in Ikena Oncology Inc. The transaction was- Published at
- by gurufocus.com
positivepositiveBIOTECHNOLOGY VALUE FUND L P Reduces Stake in Ikena Oncology Inc
Transaction Overview On December 31, 2024, BIOTECHNOLOGY VALUE FUND L P (Trades, Portfolio) executed a significant transaction involving Ikena Oncology Inc (IKN- Published at
- by manilatimes.net
negativenegative- Published at
- by zacks.com
neutralneutralIkena Oncology (IKNA) Moves to Buy: Rationale Behind the Upgrade
Ikena Oncology (IKNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.- Published at
- by finance.yahoo.com
positivepositiveIkena Oncology and Inmagene Announce Merger and Fundraising
Ikena Oncology ( (IKNA) ) has provided an announcement. Ikena Oncology and Inmagene Biopharmaceuticals have announced a definitive merger agreement, under which the combined company will focus on developing IMG-007, a monoclonal antibody aimed at treating atopic dermatitis and other inflammatory conditions. The transaction involves a private placement raising approximately $175 million, including $75 million from new and existing investors, and is expected to close in mid-2025. Following the mer- Published at
- by gurufocus.com
positivepositiveIkena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
Inmagene Biopharmaceuticals is a clinical stage company focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody with an extended half-life- Published at
- by seekingalpha.com
neutralneutralIkena Oncology and Inmagene Biopharmaceuticals announces merger (NASDAQ:IKNA)
Ikena Oncology and Inmagene Biopharmaceuticals are merging to focus on developing a monoclonal antibody for atopic dermatitis treatment.- Published at
- by investorplace.com
neutralneutralIKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the second quarter of 2024.- Published at
- by globenewswire.com
neutralneutralIkena Oncology Reports Second Quarter 2024 Financial Results
Strong financial position with $145 million in cash and investments at close of second quarter...- Published at
- by seekingalpha.com
positivepositiveWedbush downgrades Ikena, cites discontinuation of lead asset (NASDAQ:IKNA)
Wedbush has downgraded Ikena Oncology (IKNA) to neutral, citing Tuesday’s announcement that the company was discontinuing development of its lead asset, IK-930. Read more here.- Published at
- by benzinga.com
mixedmixedWhy Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Bank of Montreal (NYSE:BMO)
Loading... Loading... Shares of Bank of Montreal BMO fell sharply during Wednesday's session after the company reported worse-than-expected second-quarter fina...- Published at
- by globenewswire.com
mixedmixedC4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
Owen Hughes, Accomplished Life Sciences Executive with Deep Experience Across Investing, Operations and Governance, Appointed as Independent Member of the...- Published at
- by rttnews.com
neutralneutralPre-market Movers: MTAC, AYX, DDOG, IFF, CHGG…
The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.10 A.M. ET)..- Published at
- by etfdailynews.com
mixedmixedInvestment Analysts’ Upgrades for May 11th (ADDYY, AHT, ARCT, ARTNA, ARWR, ASHTY, AZEK, BNCDY, CELH, CLB)
Read Investment Analysts’ Upgrades for May 11th (ADDYY, AHT, ARCT, ARTNA, ARWR, ASHTY, AZEK, BNCDY, CELH, CLB) at ETF Daily NewsVUZIUSAUUBSN.MXUBSGEE.SWUBSGE.SWUBSG34.SAUBSG.SWUBSTIXTTHCBWTHCBUTHCBTHBRWTHBRUTHBRTCBKSXS.LSXISUMOSRRKSPXSYSPXSFSPX.LSPSOLOSNPOSKYTSGIOYSGIOFSGBAFSESG.PASERASEPJYSEPJFSCVLSCORSAILRXDXRPDROADPWFL.TAPWFLPUKPFPUK-WIPUK-PPUKPTONPRU.LPRU.DEPNTGPKOHPGTIPDYPYPDYPFOYSTONCRNSKFFNOVTNLSNIUN.MXNIUNGMSNCLTYNCLTFMYOMUXMLNKMLCOMKTWLSFLICYKOPNKOGO.OLKNOPKMPHJNCEJEF.MXJEFIRIXINVAHPPHIMS-WTHIMSHGVHBIOGSBDGERNGEGGECCLGECCGECFOJCYFOJCFFLTR.LETTYFADSN.MXADS.MIADS.DEADDYYADDDFACND-UNACND9843.T4507.T2378.HK0RQC.L0LHW.L0KTX.L0JRR.L0A9A.L0A54.LTHRYTCRXTACTSWBISUPNSPNV-WTSPNV-UNSPNVSELBRYRXTPDAC-UNPDACOXSQOTTROTLYOPRTOPADOFSSGOFSOAC-UNOACNKLA.MXNGLMGTAMAINLIFEKROSIKNAIFSICVXHZON-WTHZAC-WTHZAC-UNHZACHSWLFHLHITIFHITIDHITI.VHITIGXE.DEGSKGOROGMTXGLPGFGLPG.ASGLPGFSDCEGHTEADBK.PRDBK.MIDBCWGRPCSN.MXCSGNE.SWCSGN.SWCSGKFCSCRONCOWNLCOWNCMICLBCF.TOCCXCCORFASHTYARWRARTNAAOUT8NI.DE0LB2.L0JXQ.L0IYS.L0I4P.L0HEM.L0A3R.LPLNTJPMMLJPMCAHCWCAHCUCAHC- Published at
- by etfdailynews.com
mixedmixedAnalysts’ Downgrades for May 10th (AFRM, ARCH, BCC, BG, BHF, BIIB, DBSDY, DIISY, DLG, E)
Read Analysts’ Downgrades for May 10th (AFRM, ARCH, BCC, BG, BHF, BIIB, DBSDY, DIISY, DLG, E) at ETF Daily NewsZBRATHBRWTHBRUTHBRSPNV-WTSPNV-UNSPNVSOLOSMFRSJISITESGRYSDGRSACH.MXSACH-PASACHRTXRPTRPRXRMOPADONCYONC.TOOFSSGOFSNXMVISMVIN.DEMSGSMFGMCSMATMARALOGCLLLIVNINVEINSWILALIFFHRMYHCCIEQBKBHFARCHAFRM.MXAFRM0K17.LTRVC.DETGASFSTKSSQSPSCCORIDERGNXQFINPWFLPLUSPHIPDMONEMNLSPNGLMOMMSMMHTFMEOHLMND.MXLMNDLIFEKRONKLRJBSSIZEAIMXIHSBC.BAHSBC-PAHSBCHSBA.LHSB.PAHOKCYHOKCFHLDVFHLDCYHLHBCYFHBCN.MXHBC1.DEH1SB34.SAGSGI34.SAGS.MXGS.BAGSGOS.DEFSNUYFSNUFFREN.MXFRE.DEEXPDESSEIX.DEEIXE1IX34.SADIISYDBC.MXC.BACBIIBBGBCY.DEBCSN.MXBCS.BABCSBCLYFBCCBARC.L1083.HK0IJU.L0IFJ.L0A91.L0071.HK0050.HK0012.HK0005.HK0003.HKTUSYIEYSYIEFSY1.DEIKNAHDVTY0097.HK- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Lows On Monday
On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market ...